 Antibodies Epstein-Barr virus iridocorneal endothelial syndrome Antibody titers Epstein-Barr virus patients iridocorneal endothelial syndrome healthy race- age- sex-matched controls geometric mean titer IgG antibodies Epstein-Barr virus capsid antigen proportion high titers IgG antibodies Epstein-Barr virus capsid antigen equal seropositive patients iridocorneal endothelial syndrome seropositive controls seropositive patients iridocorneal endothelial syndrome seropositive controls antibodies Epstein-Barr virus-induced early antigens equal Fisher Exact Test seropositive patients iridocorneal endothelial syndrome seropositive control low undetectable levels antibodies Epstein-Barr virus-associated nuclear antigen equal Antibody levels measles virus different patients iridocorneal endothelial syndrome controls Additional studies evidence humoral immune disorder collagen vascular disease patients iridocorneal endothelial syndrome serologic profiles patients iridocorneal endothelial syndrome cellular immune abnormality sufficient reactivation latent Epstein-Barr virus infection imply role Epstein-Barr virus infection pathogenesis cases iridocorneal endothelial syndrome